Digital Health France

France AI in Ophthalmology Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

France AI in Ophthalmology Market Industry Trends and Forecast to 2034: Segmented by (Application, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $9.7 Mn Placeholder estimate
Estimate 2025 $12.2 Mn 2.5% of the global market
Projected 2034 $97.0 Mn 694.8% Adds $84.8 Mn over 9 forecast years
CAGR 2025–2034 25.9% Faster than 87% of 103 Digital Health markets here
Key players 5
  • France is 2.52% of the global market.
  • In Europe, the largest is Germany at $16.3 Mn.
  • Fastest growing: Russia at 27% a year.
  • France ranks 3rd of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$84.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
AI in Ophthalmology Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $9.7 Mn — —
2025 (base) $12.2 Mn +$2.5 Mn —
2026 (forecast) $15.4 Mn +$3.2 Mn +25.9%
2027 (forecast) $19.3 Mn +$4.0 Mn +58.5%
2028 (forecast) $24.4 Mn +$5.0 Mn +99.6%
2029 (forecast) $30.7 Mn +$6.3 Mn +151.2%
2030 (forecast) $38.6 Mn +$7.9 Mn +216.3%
2031 (forecast) $48.6 Mn +$10.0 Mn +298.2%
2032 (forecast) $61.2 Mn +$12.6 Mn +401.4%
2033 (forecast) $77.0 Mn +$15.8 Mn +531.3%
2034 (forecast) $97.0 Mn +$20.0 Mn +694.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

France AI in Ophthalmology Market Analysis at a glance
Market size, 2025$12.2 Mn placeholder estimate
Forecast, 2034$97.0 Mn placeholder estimate
Growth (CAGR), 2025–203425.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication and setting (see all)
Key playersDigital Diagnostics, Eyenuk, Google Health, Topcon, RetinAI (see all)
Regulator in FranceEU MDR and ANSMSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France AI in Ophthalmology Market Analysis Executive Summary

AI in ophthalmology reads retinal scans to screen for diabetic eye disease, glaucoma and macular degeneration.

Key segments of the AI in Ophthalmology market include application (Diabetic Retinopathy Screening, Glaucoma and Macular Degeneration) and setting (Eye Clinics, Primary Care and Pharmacies).

Bar chart: France AI in Ophthalmology market size, 2024–2034, placeholder estimates. $9.7 Mn in 2024, $12.2 Mn in 2025 and $97.0 Mn in 2034, 25.9% CAGR.
France AI in Ophthalmology market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France AI in Ophthalmology Market Dynamics

Market Growth Drivers

Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Ophthalmology market. Health systems are moving from pilots to wider use.

Opportunity

Generative AI, automation of paperwork and AI tools approved as medical devices give the AI in Ophthalmology market strong growth, including in emerging health systems.

Market Restraints

Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI in Ophthalmology market.

Competitive Landscape for AI in Ophthalmology Market in France

The AI in Ophthalmology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for AI in Ophthalmology Market in France

AI in Ophthalmology in France: rules and payment

Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device; ANSM oversees it in France.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI in Ophthalmology market. Government digital health programs in France are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in AI in Ophthalmology right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

AI in Ophthalmology in context

France compared

  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 8th highest of the 13 countries we cover in Europe.[1]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 12th highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 22.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the AI in Ophthalmology market in France?
Placeholder estimate: about $12.2 Mn in 2025, rising to about $97.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the AI in Ophthalmology market in France growing?
Placeholder estimate: about 25.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the AI in Ophthalmology market report cover?
The report splits the market by application (Diabetic Retinopathy Screening, Glaucoma, Macular Degeneration) and setting (Eye Clinics, Primary Care, Pharmacies).
Who are the key players in the AI in Ophthalmology market?
Key players include Digital Diagnostics, Eyenuk, Google Health, Topcon and RetinAI.
What is driving the AI in Ophthalmology market?
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Ophthalmology market. Health systems are moving from pilots to wider use.
Who regulates AI in Ophthalmology in France?
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device; ANSM oversees it in France. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
How much research is published on AI in Ophthalmology?
PubMed lists 80 papers on AI in Ophthalmology added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in France

See all

Related on artificial intelligence and eye health

See the topic